Related Experiment Video
Updated: May 21, 2026
Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
Published on: August 12, 2015
BRCA2 mutations and triple-negative breast cancer.
Peter Meyer1, Katharina Landgraf, Bernhard Högel
1Institute of Medical Genetics, University Hospital, Rostock, Germany. pm@uni.de
Germline mutations in BRCA2 are common in triple-negative breast cancer (TNBC), affecting 16.7% of patients studied. This suggests BRCA2 is a significant factor in TNBC development.
Area of Science:
- Oncology
- Genetics
- Cancer Research
Background:
- Triple-negative breast cancer (TNBC) is an aggressive subtype.
- BRCA1 germline mutations are frequently observed in TNBC patients.
- BRCA2 mutations have been less frequently studied in TNBC.
Purpose of the Study:
- To investigate the frequency of BRCA2 germline mutations in a cohort of triple-negative breast cancer patients.
- To compare BRCA2 mutation rates with BRCA1 mutation rates in the same TNBC cohort.
Main Methods:
- Screening of 30 unselected TNBC patients of white European descent for BRCA1 and BRCA2 germline mutations.
- Analysis included patients with varying ages at diagnosis and family cancer history.
Main Results:
- A high frequency of deleterious BRCA2 germline mutations was found (5/30, 16.7%).
- Only one patient (3.3%) had a BRCA1 germline mutation.
- Half of the patients (15/30) had a family history of breast and/or ovarian cancer.
Conclusions:
- BRCA2 germline mutations appear to be a significant factor in triple-negative breast cancer.
- Further investigation into BRCA2's role in TNBC pathogenesis is warranted.
More Related Videos
08:15gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
Published on: October 6, 2014
08:53Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
Published on: February 17, 2011
Related Concept Videos
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:33Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:33Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...